Wu, G., Dhayakar, P. (2025). Hibiscus 2 (Trial-in-Progress): A global, Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease. Blood. https://doi.org/10.1182/blood-2025-2976